SlideShare a Scribd company logo
2013 CPT
CODING
UPDATE!
CPT® is a registered
trademark of the American
Medical Association.
CPT® 2013 code changes
  announced; new codes reflect
  care advancements
 Allowphysicians to report advancements in
 healthcare services
    Molecular Tests
    Care Coordination

    SINGLE LARGEST EXPANSION
    186 New Codes Added
    119 Outdated Codes Deleted
    263 Another Revised Codes
SINGLE LARGEST EXPANSION
 Result   of:
     Significant advancements in medical
      understanding and testing for Molecular
      Disease
       Including   Human Genome Project

       The
          2013 codes include 116 for molecular
       pathology!
New Codes Will Enhance..
 Reporting of innovative diagnostic tools
 Improve Health Outcomes
 Reduce Long-Term Care Cost
 Additional Updates
     Reflect Practice Changes and
      Improvements in
       Cardiology
       Neurologic   Testing
       Psychiatry
"Medical knowledge is constantly
advancing, and as steward of CPT, the
AMA invests extensive resources each year
to keep the code set current with
contemporary medical science and
technology," AMA President Jeremy A.
Lazarus, MD
When is the code set
             updated?
   The code set is updated annually with direct
    input from the health care community:
       Practicing Physicians
       Allied Health Professionals
       Advisors from more than 100 medical specialty
        societies

       Such input has allowed the code set to better
        support the reporting needs of physicians and
        other professionals in emerging models of care,
        including patient-centered medical homes and
        accountable care organizations.
Click here for the 2013 CPT
code changes
 "Tapping  into the clinical expertise of the
 health care community produces the
 practical enhancements that CPT needs
 to reflect the coding demands of the
 modern health care system," Dr. Lazarus
 said.
A few CPT 2013 CPT codes..
        Arthrodesis, pre-sacral interbody technique, including disc space
        preparation, discectomy,with posterior instrumentation, with image
        guidance, includes bone graft, when performed,lumbar, L4-L5
        interspace (List separately in addition to code for primary
0309T   procedure
        Motor function mapping using non-invasive navigated transcranial
        magnetic stimulation(nTMS) for therapeutic treatment planning,
0310T   upper and lower extremity
        Non-invasive calculation and analysis of central arterial pressure
0311T   waveforms withinterpretation and report
        Vagus nerve blocking therapy (morbid obesity); laparoscopic
        implantation of neurostimulator electrode array, anterior and
        posterior vagal trunks adjacent to esophagogastric junction(EGJ),
0312T   with implantation of pulse generator, includes programming
        Vagus nerve blocking therapy (morbid obesity); laparoscopic
        revision or replacement of vagaltrunk neurostimulator electrode
0313T   array, including connection to existing pulse generator
Vagus nerve blocking therapy (morbid obesity); laparoscopic
        removal of vagal trunkneurostimulator electrode array and pulse
0314T   generator


        Vagus nerve blocking therapy (morbid obesity); removal of pulse
        generator agus nerve blocking therapy (morbid obesity); removal of
0315T   pulse generator

        Vagus nerve blocking therapy (morbid obesity); replacement of
0316T   pulse generator

        Vagus nerve blocking therapy (morbid obesity); neurostimulator pulse
        generator electronicanalysis, includes reprogramming when
        performed
0317T



        Implantation of catheter-delivered prosthetic aortic heart valve,
0318T   open thoracic approach, (eg,transapical, other than transaortic)
Implantation of catheter-delivered prosthetic aortic heart valve,
0319T   open thoracic approach, (eg,transapical, other than transaortic


0320T   Insertion of subcutaneous defibrillator electrode




        Insertion of subcutaneous implantable defibrillator pulse generator
0321T   only with existingsubcutaneous electrode

        Removal of subcutaneous implantable defibrillator pulse generator
0322T   only


        Removal of subcutaneous implantable defibrillator pulse generator
        with replacement of subcutaneous implantable defibrillator pulse
0323T   generator only
0324T   Removal of subcutaneous defibrillator electrode
        Repositioning of subcutaneous implantable defibrillator electrode
0325T   and/or pulse generator
        Electrophysiologic evaluation of subcutaneous implantable
        defibrillator (includes defibrillationthreshold evaluation, induction of
        arrhythmia, evaluation of sensing for arrhythmiatermination, and
        programming or reprogramming of sensing or therapeutic
0326T   parameters
        Interrogation device evaluation (in person) with analysis, review and
        report, includesconnection, recording and disconnection per
        patient encounter; implantable subcutaneouslead defibrillator
0327T   system

        Programming device evaluation (in person) with iterative
        adjustment of the implantable deviceto test the function of the
        device and select optimal permanent programmed values
0328T   withanalysis; implantable subcutaneous lead defibrillator system
0580F   Multidisciplinary care plan developed or updated (DSP)

        Patient transferred directly from anesthetizing location to critical care
0581F   unit (Peri2)



        Patient not transferred directly from anesthetizing location to critical
0582F   care unit (Peri2)


0583F   Transfer of care checklist used (Peri2)


0584F   Transfer of care checklist not used (Peri2)
Did we say a few?
        Symptoms and signs of distal symmetric polyneuropathy reviewed
1500F   and documented (DSP)

1501F   Not initial evaluation for condition (DSP



        Patient queried about pain and pain interference with function
1502F   using a valid and reliableinstrument (DSP

1503F   Patient queried about symptoms of respiratory insufficiency (DSP)

1504F   Patient has respiratory insufficiency (DSP
Arthrodesis, pre-sacral interbody technique, including disc space
        preparation, discectomy,with posterior instrumentation, with image
22586   guidance, includes bone graft when performed, L5-S1 interspace

        Revision of total shoulder arthroplasty, including allograft when
23473   performed; humeral or glenoidcomponent

        Revision of total shoulder arthroplasty, including allograft when
23474   performed; humeral andglenoid component

        Revision of total elbow arthroplasty, including allograft when
24370   performed; humeral or ulnar component

        Revision of total elbow arthroplasty, including allograft when
24371   performed; humeral and ulnar component
Bronchoscopy, rigid or flexible, including fluoroscopic
        guidance, when performed; with balloonocclusion, when
        performed, assessment of air leak, airway sizing, and
31647   insertion of bronchialvalve(s), initial lobe
        Bronchoscopy, rigid or flexible, including fluoroscopic
        guidance, when performed; withremoval of bronchial
31648   valve(s), initial lobe
        Bronchoscopy, rigid or flexible, including fluoroscopic
        guidance, when performed; withremoval of bronchial
        valve(s), each additional lobe (List separately in addition to
31649   code for primary procedure)
        Bronchoscopy, rigid or flexible, including fluoroscopic
        guidance, when performed; with balloonocclusion, when
        performed, assessment of air leak, airway sizing, and
        insertion of bronchialvalve(s), each additional lobe (List
31651   separately in addition to code for primary procedure[s]
        Bronchoscopy, rigid or flexible, including fluoroscopic
        guidance, when performed; withbronchial thermoplasty, 1
31660   lobe
Bronchoscopy, rigid or flexible, including fluoroscopic
31661   guidance, when performed; withbronchial thermoplasty,
        2 or more lobes

        Thoracentesis, needle or catheter, aspiration of
32554
        the pleural space; without imaging guidance

        Thoracentesis, needle or catheter, aspiration of
32555
        the pleural space; with imaging guidance

        Pleural drainage, percutaneous, with insertion of
32556
        indwelling catheter; without imagingguidance

        Pleural drainage, percutaneous, with insertion of
32557
        indwelling catheter; with imaging guidance
Thoracic target(s) delineation for stereotactic body
32701   radiation therapy (SRS/SBRT), (photon or particle beam),
        entire course of treatment

        Transcatheter aortic valve replacement (TAVR/TAVI) with
33361
        prosthetic valve; percutaneousfemoral artery approach

        Transcatheter aortic valve replacement (TAVR/TAVI) with
33362
        prosthetic valve; open femoralartery approach

        Transcatheter aortic valve replacement (TAVR/TAVI) with
33363
        prosthetic valve; open axillaryartery approach

        Transcatheter aortic valve replacement (TAVR/TAVI) with
33364
        prosthetic valve; open iliac arteryapproach
Transcatheter aortic valve replacement (TAVR/TAVI) with
33365   prosthetic valve; transaorticapproach (eg, median
        sternotomy, mediastinotomy)
        Transcatheter aortic valve replacement (TAVR/TAVI) with
        prosthetic valve; cardiopulmonarybypass support with
33367   percutaneous peripheral arterial and venous cannulation
        (eg, femoralvessels) (List separately in addition to code
        for primary procedure)
        Transcatheter aortic valve replacement (TAVR/TAVI) with
        prosthetic valve; cardiopulmonarybypass support with
33368   open peripheral arterial and venous cannulation (eg,
        femoral, iliac,axillary vessels) (List separately in addition to
        code for primary procedure)
        Transcatheter aortic valve replacement (TAVR/TAVI) with
        prosthetic valve; cardiopulmonarybypass support with
33369   central arterial and venous cannulation (eg, aorta, right
        atrium,pulmonary artery) (List separately in addition
        to code for primary procedure)
        Insertion of ventricular assist device, percutaneous
33990   including radiological supervision andinterpretation;
        arterial access only
        Insertion of ventricular assist device, percutaneous
33991   including radiological supervision andinterpretation; both
        arterial and venous access, with transseptal puncture
Removal of percutaneous ventricular assist device at
33992
        separate and distinct session frominsertion
        Repositioning of percutaneous ventricular assist device
33993   with imaging guidance at separateand distinct session
        from insertion
        Non-selective catheter placement, thoracic aorta, with
        angiography of the extracranial carotid,vertebral, and/or
        intracranial vessels, unilateral or bilateral, and all
36221
        associated radiologicalsupervision and interpretation,
        includes angiography of the cervicocerebral arch,
        whenperformed
        Selective catheter placement, common carotid or
        innominate artery, unilateral, any approach,with
        angiography of the ipsilateral extracranial carotid
36222
        circulation and all associatedradiological supervision and
        interpretation, includes angiography of the
        cervicocerebral arch,when performed
        Selective catheter placement, common carotid or
        innominate artery, unilateral, any approach,with
        angiography of the ipsilateral intracranial carotid
36223
        circulation and all associatedradiological supervision and
        interpretation, includes angiography of the extracranial
        carotidand cervicocerebral arch, when performed
Selective catheter placement, internal carotid artery,
        unilateral, with angiography of theipsilateral intracranial
        carotid circulation and all associated radiological
36224
        supervision andinterpretation, includes angiography of the
        extracranial carotid and cervicocerebral arch,when
        performed
        Selective catheter placement, subclavian or innominate
        artery, unilateral, with angiography of the ipsilateral
36225   vertebral circulation and all associated radiological
        supervision andinterpretation, includes angiography of the
        cervicocerebral arch, when performed
        Selective catheter placement, vertebral artery, unilateral,
        with angiography of the ipsilateralvertebral circulation and
36226   all associated radiological supervision and interpretation,
        includesangiography of the cervicocerebral arch, when
        performed
        Selective catheter placement, external carotid artery,
        unilateral, with angiography of theipsilateral external carotid
36227   circulation and all associated radiological supervision
        andinterpretation (List separately in addition to code for
        primary procedure)
        Selective catheter placement, each intracranial branch of
        the internal carotid or vertebralarteries, unilateral, with
        angiography of the selected vessel circulation and all
36228
        associatedradiological supervision and interpretation (eg,
        middle cerebral artery, posterior inferior cerebellar artery)
        (List separately in addition to code for primary procedure)
Transcatheter retrieval, percutaneous, of intravascular
        foreign body (eg, fractured venous or arterial catheter),
37197   includes radiological supervision and interpretation, and
        imaging guidance(ultrasound or fluoroscopy), when
        performed
        Transcatheter therapy, arterial infusion for thrombolysis
37211   other than coronary, any method,including radiological
        supervision and interpretation, initial treatment day
        Transcatheter therapy, venous infusion for thrombolysis, any
37212   method, including radiologicalsupervision and
        interpretation, initial treatment day

        Transcatheter therapy, arterial or venous infusion for
        thrombolysis other than coronary, anymethod, including
        radiological supervision and interpretation, continued
37213
        treatment onsubsequent day during course of thrombolytic
        therapy, including follow-up catheter contrastinjection,
        position change, or exchange, when performed;

        Transcatheter therapy, arterial or venous infusion for
        thrombolysis other than coronary, anymethod, including
        radiological supervision and interpretation, continued
        treatment onsubsequent day during course of thrombolytic
37214
        therapy, including follow-up catheter contrastinjection,
        position change, or exchange, when performed; cessation
        of thrombolysis includingremoval of catheter and vessel
        closure by any method
Electrodiagnostic studies for distal symmetric
        polyneuropathy not conducted (or
3752F
        requested),documented, or reviewed within 6 months of
        initial evaluation for condition (DSP)

        Patient has clear clinical symptoms and signs that
        are highly suggestive of neuropathy ANDcannot be
3753F
        attributed to another condition, AND has an obvious
        cause for the neuropathy(DSP)

        Screening tests for diabetes mellitus reviewed, requested,
3754F
        or ordered (DSP)

        Cognitive and behavioral impairment screening
3755F
        performed (DSP)

        Patient has pseudobulbar affect, sialorrhea, or
3756F
        ALS related symptoms (DSP)

        Patient does not have pseudobulbar affect, sialorrhea, or
3757F
        ALS related symptoms (DSP)

        Patient referred for pulmonary function testing or peak
3758F
        cough expiratory flow (DSP)
Take effect January 1, 2013..
        Patient screened for dysphagia, weight loss, and
3759F
        impaired nutrition, and results documented(DSP)

        Patient exhibits dysphagia, weight loss, or impaired
3760F
        nutrition (DSP)

        Patient does not exhibit dysphagia, weight loss, or
3761F
        impaired nutrition (DSP)

3762F   Patient is dysarthric (DSP)

3763F   Patient is not dysarthric (DSP)

38243   Hematopoietic progenitor cell (HPC); HPC boost

        Esophagoscopy, rigid or flexible; with optical
43206
        endomicroscopy
Upper gastrointestinal endoscopy including esophagus,
43252   stomach, and either the duodenumand/or jejunum as
        appropriate; with optical endomicroscopy

        Preparation of fecal microbiota for instillation,
44705
        including assessment of donor specimen

4540F   Disease modifying pharmacotherapy discussed (DSP)

        Patient offered treatment for pseudobulbar affect,
4541F
        sialorrhea, or ALS related symptoms (DSP)

        Options for noninvasive respiratory support discussed with
4550F
        patient (DSP)

4551F   Nutritional support offered (DSP)

        Patient offered referral to a speech language pathologist
4552F
        (DSP)
Patient offered assistance in planning for end of life issues
4553F
        (DSP)

4554F   Patient received inhalational anesthetic agent (Peri2)

        Patient did not receive inhalational anesthetic
4555F
        agent (Peri2)

        Patient exhibits 3 or more risk factors for post-operative
4556F
        nausea and vomiting (Peri2)

        Patient does not exhibit 3 or more risk factors for post-
4557F
        operative nausea and vomiting (Peri2)

        Patient received at least 2 prophylactic pharmacologic
4558F   anti-emetic agents of different classespreoperatively and
        intraoperatively (Peri2)

         At least 1 body temperature measurement equal to or
        greater than 35.5 degrees Celsius (or 95.9 degrees
4559F   Fahrenheit) recorded within the 30 minutes immediately
        before or the 15minutes immediately after anesthesia end
        time (Peri2)
Anesthesia technique did not involve general or neuraxial
4560F
        anesthesia (Peri2)


4561F   Patient has a coronary artery stent (Peri2)


4562F   Patient does not have a coronary artery stent (Peri2)


        Patient received aspirin within 24 hours prior to anesthesia
4563F
        start time (Peri2)

        Cystourethroscopy, with injection(s) for chemodenervation
52287
        of the bladder

        Chemodenervation of muscle(s); muscle(s) innervated by
64615   facial, trigeminal, cervical spinaland accessory nerves,
        bilateral (eg, for chronic migraine)

        Thyroid uptake, single or multiple quantitative
78012   measurement(s) (including stimulation,suppression, or
        discharge, when performed)
Thyroid imaging (including vascular flow, when
78013
        performed);

        Thyroid imaging (including vascular flow, when
        performed); with single or multiple uptake(s)quantitative
78014
        measurement(s) (including stimulation, suppression, or
 c     discharge, whenperformed)

        Parathyroid planar imaging (including subtraction, when
78071
        performed); with tomographic(SPECT)

        Parathyroid planar imaging (including subtraction, when
        performed); with tomographic(SPECT), and concurrently
78072
        acquired computed tomography (CT) for anatomical
        localization

        DMD (dystrophin) (eg, Duchenne/Becker muscular
81161   dystrophy) deletion analysis, andduplication analysis, if
        performed

        APC (adenomatous polyposis coli) (eg, familial
81201   adenomatosis polyposis [FAP], attenuatedFAP) gene
        analysis; full gene sequence
APC (adenomatous polyposis coli) (eg, familial
81202   adenomatosis polyposis [FAP], attenuatedFAP) gene
        analysis; known familial variants

        APC (adenomatous polyposis coli) (eg, familial
81203   adenomatosis polyposis [FAP], attenuatedFAP) gene
        analysis; duplication/deletion variants

        EGFR (epidermal growth factor receptor) (eg, non-
        small cell lung cancer) gene analysis,common variants
81235
        (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S,
        L861Q)

        GJB2 (gap junction protein, beta 2, 26kDa; connexin 26)
81252   (eg, nonsyndromic hearing loss)gene analysis; full gene
        sequence

        GJB2 (gap junction protein, beta 2, 26kDa; connexin 26)
81253   (eg, nonsyndromic hearing loss)gene analysis; known
        familial variants
GJB6 (gap junction protein, beta 6, 30kDa, connexin 30)
        (eg, nonsyndromic hearing loss)gene analysis, common
81254
        variants (eg, 309kb [del(GJB6-D13S1830)] and
        232kb [del(GJB6-D13S1854)])

        PTEN (phosphatase and tensin homolog) (eg,
81321   Cowden syndrome, PTEN hamartoma tumor syndrome)
        gene analysis; full sequence analysis

        PTEN (phosphatase and tensin homolog) (eg,
81322   Cowden syndrome, PTEN hamartoma tumor syndrome)
        gene analysis; known familial variant

        PTEN (phosphatase and tensin homolog) (eg,
81323   Cowden syndrome, PTEN hamartoma tumor syndrome)
        gene analysis; duplication/deletion variant


        PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-
81324   Tooth, hereditary neuropathy withliability to pressure
        palsies) gene analysis; duplication/deletion analysis
PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-
81325   Tooth, hereditary neuropathy withliability to pressure
        palsies) gene analysis; full sequence analysis

        PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-
81326   Tooth, hereditary neuropathy withliability to pressure
        palsies) gene analysis; known familial variant

81479   Unlisted molecular pathology procedure

        Oncology (ovarian), biochemical assays of two proteins
81500   (CA-125 and HE4), utilizing serum,with menopausal status,
        algorithm reported as a risk score

        Oncology (ovarian), biochemical assays of five proteins
        (CA-125, apolipoprotein A1, beta-2microglobulin,
81503
        transferrin and pre-albumin), utilizing serum, algorithm
        reported as a risk score

        Endocrinology (type 2 diabetes), biochemical assays of
        seven analytes (glucose, HbA1c,insulin, hs-CRP,
81506
        adiponectin, ferritin, interleukin 2-receptor alpha), utilizing
        serum or plasma,algorithm reporting a risk score
Fetal congenital abnormalities, biochemical assays of two
81508   proteins (PAPP-A, hCG [anyform]), utilizing maternal serum,
        algorithm reported as a risk score

        Fetal congenital abnormalities, biochemical assays of
81509   three proteins (PAPP-A, hCG [anyform], DIA), utilizing
        maternal serum, algorithm reported as a risk score

        Fetal congenital abnormalities, biochemical assays of
81510   three analytes (AFP, uE3, hCG [anyform]), utilizing
        maternal serum, algorithm reported as a risk score

        Fetal congenital abnormalities, biochemical assays of four
        analytes (AFP, uE3, hCG [anyform], DIA) utilizing maternal
81511   serum, algorithm reported as a risk score (may
        includeadditional results from previous biochemical
        testing)

        Fetal congenital abnormalities, biochemical assays of five
        analytes (AFP, uE3, total hCG,hyperglycosylated hCG,
81512
        DIA) utilizing maternal serum, algorithm reported as a risk
        score

81599   Unlisted multianalyte assay with algorithmic analysis
82777   Galectin-3

        Cell enumeration using immunologic selection and
86152   identification in fluid specimen (eg,circulating tumor cells in
        blood);

        Cell enumeration using immunologic selection and
86153   identification in fluid specimen (eg,circulating tumor cells in
        blood); physician interpretation and report, when required

86711   Antibody; JC (John Cunningham) virus

        Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, flow cytometry);
86828
        qualitative assessment of the presence or absence
        of antibody(ies) to HLA Class I and Class II HLA antigens

        Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, Flow cytometry);
86829
        qualitative assessment of the presence or absence
        of antibody(ies) to HLA Class I or Class II HLA antigens
Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, Flow cytometry);
86830
        antibody identification by qualitative panel using
        completeHLA phenotypes, HLA Class I

        Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, Flow cytometry);
86831
        antibody identification by qualitative panel using
        completeHLA phenotypes, HLA Class II

        Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, Flow cytometry);
86832   high definition qualitative panel for identification of
        antibodyspecificities (eg, individual antigen per
        bead methodology), HLA Class I

        Antibody to human leukocyte antigens (HLA), solid phase
        assays (eg, microspheres or beads, ELISA, Flow cytometry);
86833   high definition qualitative panel for identification of
        antibodyspecificities (eg, individual antigen per
        bead methodology), HLA Class II

         Antibody to human leukocyte antigens (HLA), solid phase
86834   assays (eg, microspheres or beads, ELISA, Flow cytometry);
        semi-quantitative panel (eg, titer), HLA Class I
Antibody to human leukocyte antigens (HLA), solid phase assays (eg,
86835   microspheres or beads, ELISA, Flow cytometry); semi-quantitative
        panel (eg, titer), HLA Class II

        Infectious agent detection by nucleic acid (DNA or RNA); respiratory
        virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus,
87631   parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex
        reverse transcription and amplified probe technique, multipletypes or
        subtypes, 3-5 targets

        Infectious agent detection by nucleic acid (DNA or RNA); respiratory
        virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus,
87632   parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex
        reverse transcription and amplified probe technique, multipletypes or
        subtypes, 6-11 targets

        Infectious agent detection by nucleic acid (DNA or RNA); respiratory
        virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus,
87633   parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex
        reverse transcription and amplified probe technique, multipletypes or
        subtypes, 12-25 targets

        Infectious agent genotype analysis by nucleic acid (DNA or RNA);
87910
        cytomegalovirus

        Infectious agent genotype analysis by nucleic acid (DNA or RNA);
87912
        Hepatitis B virus
Optical endomicroscopic image(s), interpretation and report, real-
88375
        time or referred, eachendoscopic session

        Influenza vaccine, inactivated, subunit, adjuvanted, for
90653
        intramuscular use


90672   Influenza virus vaccine, quadrivalent, live, for intranasal use


        Influenza virus vaccine, quadrivalent, split virus, preservative
90685   free, when administered tochildren 6-35 months of age, for
        intramuscular use

        Influenza virus vaccine, quadrivalent, split virus, preservative
90686   free, when administered toindividuals 3 years of age and older, for
        intramuscular use


        Influenza virus vaccine, quadrivalent, split virus, when administered to
90687
        children 6-35 monthsof age, for intramuscular use


        Influenza virus vaccine, quadrivalent, split virus, when administered to
90688
        individuals 3 years of age and older, for intramuscular use


        Hepatitis B vaccine, adult dosage (2 dose schedule), for
90739
        intramuscular use
Interactive complexity (List separately in addition to the
90785
        code for primary procedure)

90791   Psychiatric diagnostic evaluation

90792   Psychiatric diagnostic evaluation with medical services

        Psychotherapy, 30 minutes with patient and/or family
90832
        member

        Psychotherapy, 30 minutes with patient and/or family
        member when performed with anevaluation and
90833
        management service (List separately in addition to the
        code for primaryprocedure)

        Psychotherapy, 45 minutes with patient and/or family
90834
        member

        Psychotherapy, 45 minutes with patient and/or family
        member when performed with anevaluation and
90836
        management service (List separately in addition to the
        code for primaryprocedure)
Psychotherapy, 60 minutes with patient and/or family
90837
        member

        Psychotherapy, 60 minutes with patient and/or family
        member when performed with anevaluation and
90838
        management service (List separately in addition to the code
        for primaryprocedure)

90839   Psychotherapy for crisis; first 60 minutes

        Psychotherapy for crisis; each additional 30 minutes (List
90840
        separately in addition to code for primary service)

        Pharmacologic management, including prescription and
        review of medication, whenperformed with psychotherapy
90863
        services (List separately in addition to the code for
        primaryprocedure)

        Gastrointestinal transit and pressure measurement, stomach
91112   through colon, wireless capsule,with interpretation and
        report
        Percutaneous transluminal coronary angioplasty; single
92920
        major coronary artery or branch
Get more educational
information on the next slide!
        Percutaneous transluminal coronary angioplasty; each
92921   additional branch of a major coronaryartery (List
        separately in addition to code for primary procedure)
        Percutaneous transluminal coronary atherectomy, with
92924   coronary angioplasty when performed;single major
        coronary artery or branch
        Percutaneous transluminal coronary atherectomy, with
92925   coronary angioplasty when performed;each additional
        branch of a major coronary artery (List separately in
        addition to code for primary procedure)
Want to learn more?
   Interested in getting more educational
    information? Click here for free white papers
    and research reports!
   Reports & Data
   Upcoming Webinars!
   CPT Codes
   The Institute for Health Technology
    Transformation is the leading organization
    committed to bringing together private and
    public sector leaders fostering the growth and
    effective use of technology across the
    healthcare industry.
   PowerPoint brought to you by iHT2Blog.com

More Related Content

What's hot

2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
Centro Diagnostico Nardi
 
Stentectomy of detached Solitaire – Novel techniques
Stentectomy of detached Solitaire – Novel techniquesStentectomy of detached Solitaire – Novel techniques
Stentectomy of detached Solitaire – Novel techniques
Dr Vipul Gupta
 
Advancements in Rodent Surgical Monitoring
Advancements in Rodent Surgical MonitoringAdvancements in Rodent Surgical Monitoring
Advancements in Rodent Surgical Monitoring
InsideScientific
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
Jose Osorio
 
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
InsideScientific
 
AICD programming
AICD programmingAICD programming
AICD programming
PRAVEEN GUPTA
 
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting developmentKedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
International Chair on Interventional Cardiology and Transradial Approach
 
Mechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retrieverMechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retriever
Dr Vipul Gupta
 
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
Cardiovascular Diagnosis and Therapy (CDT)
 
Trial e crt
Trial e crtTrial e crt
Trial e crt
Giuseppe Arena
 
Stroke EVT- A Discussion
Stroke EVT- A DiscussionStroke EVT- A Discussion
Stroke EVT- A Discussion
Dr Vipul Gupta
 
Crt
CrtCrt
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
Dr Vipul Gupta
 
Stroke EVT - Panel Discussion
Stroke EVT - Panel DiscussionStroke EVT - Panel Discussion
Stroke EVT - Panel Discussion
Dr Vipul Gupta
 
Cardiac resynchronization
Cardiac resynchronizationCardiac resynchronization
Cardiac resynchronization
mariebma
 
Jorge palazuelos icp en lesiones severamente calcificadas
Jorge palazuelos icp en lesiones severamente calcificadasJorge palazuelos icp en lesiones severamente calcificadas
Jorge palazuelos icp en lesiones severamente calcificadas
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua
Hiralal Pawar
 
Ponencia ISBT-SETS MADRID 2007
Ponencia  ISBT-SETS MADRID 2007Ponencia  ISBT-SETS MADRID 2007
Ponencia ISBT-SETS MADRID 2007
José Antonio García Erce
 
How to reduce time between patient arrival and puncture
How to reduce time between patient arrival and punctureHow to reduce time between patient arrival and puncture
How to reduce time between patient arrival and puncture
Dr Vipul Gupta
 
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heartGilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
International Chair on Interventional Cardiology and Transradial Approach
 

What's hot (20)

2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
2006 orvieto, workshop interattivo. la terapia elettrica dello scompenso card...
 
Stentectomy of detached Solitaire – Novel techniques
Stentectomy of detached Solitaire – Novel techniquesStentectomy of detached Solitaire – Novel techniques
Stentectomy of detached Solitaire – Novel techniques
 
Advancements in Rodent Surgical Monitoring
Advancements in Rodent Surgical MonitoringAdvancements in Rodent Surgical Monitoring
Advancements in Rodent Surgical Monitoring
 
Cardiac resynchronization therapy
Cardiac resynchronization therapyCardiac resynchronization therapy
Cardiac resynchronization therapy
 
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
Improving Rodent Cardiovascular Research Outcomes with Integrated Surgical Mo...
 
AICD programming
AICD programmingAICD programming
AICD programming
 
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting developmentKedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
Kedev S - AIMRADIAL 2014 Endovascular - Carotid stenting development
 
Mechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retrieverMechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retriever
 
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
Electrocardiograhic findings resulting in inappropriate cardiac catheterizati...
 
Trial e crt
Trial e crtTrial e crt
Trial e crt
 
Stroke EVT- A Discussion
Stroke EVT- A DiscussionStroke EVT- A Discussion
Stroke EVT- A Discussion
 
Crt
CrtCrt
Crt
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
 
Stroke EVT - Panel Discussion
Stroke EVT - Panel DiscussionStroke EVT - Panel Discussion
Stroke EVT - Panel Discussion
 
Cardiac resynchronization
Cardiac resynchronizationCardiac resynchronization
Cardiac resynchronization
 
Jorge palazuelos icp en lesiones severamente calcificadas
Jorge palazuelos icp en lesiones severamente calcificadasJorge palazuelos icp en lesiones severamente calcificadas
Jorge palazuelos icp en lesiones severamente calcificadas
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua
 
Ponencia ISBT-SETS MADRID 2007
Ponencia  ISBT-SETS MADRID 2007Ponencia  ISBT-SETS MADRID 2007
Ponencia ISBT-SETS MADRID 2007
 
How to reduce time between patient arrival and puncture
How to reduce time between patient arrival and punctureHow to reduce time between patient arrival and puncture
How to reduce time between patient arrival and puncture
 
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heartGilchrist IC - AIMRADIAL 2014 Technical - Right heart
Gilchrist IC - AIMRADIAL 2014 Technical - Right heart
 

Similar to 2013 CPT Coding Update!

2023 CPT® Code Updates (Physician Focused)
2023 CPT® Code Updates (Physician Focused)2023 CPT® Code Updates (Physician Focused)
2023 CPT® Code Updates (Physician Focused)
Health Catalyst
 
Coding Accurately for Echocardiography Services
Coding Accurately for Echocardiography ServicesCoding Accurately for Echocardiography Services
Coding Accurately for Echocardiography Services
Outsource Strategies International
 
miyazaki2013.pdf
miyazaki2013.pdfmiyazaki2013.pdf
miyazaki2013.pdf
TejaLaksana2
 
Transcatheter mitral valve repair
Transcatheter mitral valve repairTranscatheter mitral valve repair
Transcatheter mitral valve repair
https://aiimsbhubaneswar.nic.in/
 
Managment DVR Surgery
Managment DVR SurgeryManagment DVR Surgery
Managment DVR Surgery
Nilesh Parmar
 
Managment for dvr surgery
Managment for dvr surgeryManagment for dvr surgery
Managment for dvr surgery
Nilesh Parmar
 
Utility of balloon assisted technique in trans catheter closure of very larg...
Utility of balloon assisted technique in trans catheter closure of  very larg...Utility of balloon assisted technique in trans catheter closure of  very larg...
Utility of balloon assisted technique in trans catheter closure of very larg...
Cardiovascular Diagnosis and Therapy (CDT)
 
Desun Hospital Health Insights : Modern Approach on Angioplasty
Desun Hospital Health Insights : Modern Approach on AngioplastyDesun Hospital Health Insights : Modern Approach on Angioplasty
Desun Hospital Health Insights : Modern Approach on Angioplasty
DESUN Hospital
 
2015 CPT Updates
2015 CPT Updates2015 CPT Updates
2024 CPT® Code Updates (HIM Focused) - Part 2
2024 CPT® Code Updates (HIM Focused) - Part 22024 CPT® Code Updates (HIM Focused) - Part 2
2024 CPT® Code Updates (HIM Focused) - Part 2
Health Catalyst
 
Elec ii
Elec iiElec ii
Elec ii
hatch_jane
 
2012 CPT Coding Changes
2012 CPT Coding Changes2012 CPT Coding Changes
2012 CPT Coding Changes
ReimbursementMD
 
2023 Mid-Year CPT/HCPCS Code Set Updates
2023 Mid-Year CPT/HCPCS Code Set Updates2023 Mid-Year CPT/HCPCS Code Set Updates
2023 Mid-Year CPT/HCPCS Code Set Updates
Health Catalyst
 
Stroke Treatment Algorithm and Real life experience with implementation of st...
Stroke Treatment Algorithm and Real life experience with implementation of st...Stroke Treatment Algorithm and Real life experience with implementation of st...
Stroke Treatment Algorithm and Real life experience with implementation of st...
GautamD6
 
Ultrasound Coding Questions By Acr Aug2009
Ultrasound Coding Questions By Acr Aug2009Ultrasound Coding Questions By Acr Aug2009
Ultrasound Coding Questions By Acr Aug2009
draymond54
 
TEVAR.pptx
TEVAR.pptxTEVAR.pptx
TEVAR.pptx
Hossam atef
 
EDM+ Product Brochure 9051-5613 Issue 1-2-2
EDM+ Product Brochure 9051-5613 Issue 1-2-2EDM+ Product Brochure 9051-5613 Issue 1-2-2
EDM+ Product Brochure 9051-5613 Issue 1-2-2
Jennifer Monier
 
Hofer ct teaching manual - a systematic approach to ct reading, 2nd ed.
Hofer   ct teaching manual - a systematic approach to ct reading,  2nd ed.Hofer   ct teaching manual - a systematic approach to ct reading,  2nd ed.
Hofer ct teaching manual - a systematic approach to ct reading, 2nd ed.
Michel Phuong
 
Hypertension XCEL PWV validation
Hypertension XCEL PWV validationHypertension XCEL PWV validation
Hypertension XCEL PWV validation
Eugenie Millet-Amaury
 
S436.full
S436.fullS436.full
S436.full
Carlos Mantilla
 

Similar to 2013 CPT Coding Update! (20)

2023 CPT® Code Updates (Physician Focused)
2023 CPT® Code Updates (Physician Focused)2023 CPT® Code Updates (Physician Focused)
2023 CPT® Code Updates (Physician Focused)
 
Coding Accurately for Echocardiography Services
Coding Accurately for Echocardiography ServicesCoding Accurately for Echocardiography Services
Coding Accurately for Echocardiography Services
 
miyazaki2013.pdf
miyazaki2013.pdfmiyazaki2013.pdf
miyazaki2013.pdf
 
Transcatheter mitral valve repair
Transcatheter mitral valve repairTranscatheter mitral valve repair
Transcatheter mitral valve repair
 
Managment DVR Surgery
Managment DVR SurgeryManagment DVR Surgery
Managment DVR Surgery
 
Managment for dvr surgery
Managment for dvr surgeryManagment for dvr surgery
Managment for dvr surgery
 
Utility of balloon assisted technique in trans catheter closure of very larg...
Utility of balloon assisted technique in trans catheter closure of  very larg...Utility of balloon assisted technique in trans catheter closure of  very larg...
Utility of balloon assisted technique in trans catheter closure of very larg...
 
Desun Hospital Health Insights : Modern Approach on Angioplasty
Desun Hospital Health Insights : Modern Approach on AngioplastyDesun Hospital Health Insights : Modern Approach on Angioplasty
Desun Hospital Health Insights : Modern Approach on Angioplasty
 
2015 CPT Updates
2015 CPT Updates2015 CPT Updates
2015 CPT Updates
 
2024 CPT® Code Updates (HIM Focused) - Part 2
2024 CPT® Code Updates (HIM Focused) - Part 22024 CPT® Code Updates (HIM Focused) - Part 2
2024 CPT® Code Updates (HIM Focused) - Part 2
 
Elec ii
Elec iiElec ii
Elec ii
 
2012 CPT Coding Changes
2012 CPT Coding Changes2012 CPT Coding Changes
2012 CPT Coding Changes
 
2023 Mid-Year CPT/HCPCS Code Set Updates
2023 Mid-Year CPT/HCPCS Code Set Updates2023 Mid-Year CPT/HCPCS Code Set Updates
2023 Mid-Year CPT/HCPCS Code Set Updates
 
Stroke Treatment Algorithm and Real life experience with implementation of st...
Stroke Treatment Algorithm and Real life experience with implementation of st...Stroke Treatment Algorithm and Real life experience with implementation of st...
Stroke Treatment Algorithm and Real life experience with implementation of st...
 
Ultrasound Coding Questions By Acr Aug2009
Ultrasound Coding Questions By Acr Aug2009Ultrasound Coding Questions By Acr Aug2009
Ultrasound Coding Questions By Acr Aug2009
 
TEVAR.pptx
TEVAR.pptxTEVAR.pptx
TEVAR.pptx
 
EDM+ Product Brochure 9051-5613 Issue 1-2-2
EDM+ Product Brochure 9051-5613 Issue 1-2-2EDM+ Product Brochure 9051-5613 Issue 1-2-2
EDM+ Product Brochure 9051-5613 Issue 1-2-2
 
Hofer ct teaching manual - a systematic approach to ct reading, 2nd ed.
Hofer   ct teaching manual - a systematic approach to ct reading,  2nd ed.Hofer   ct teaching manual - a systematic approach to ct reading,  2nd ed.
Hofer ct teaching manual - a systematic approach to ct reading, 2nd ed.
 
Hypertension XCEL PWV validation
Hypertension XCEL PWV validationHypertension XCEL PWV validation
Hypertension XCEL PWV validation
 
S436.full
S436.fullS436.full
S436.full
 

More from Health IT Conference – iHT2

2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
Health IT Conference – iHT2
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
Health IT Conference – iHT2
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
Health IT Conference – iHT2
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
Health IT Conference – iHT2
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
Health IT Conference – iHT2
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
Health IT Conference – iHT2
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
Health IT Conference – iHT2
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
Health IT Conference – iHT2
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
Health IT Conference – iHT2
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
Health IT Conference – iHT2
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
Health IT Conference – iHT2
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit 2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
Health IT Conference – iHT2
 
iHT2 Health IT Beverly Hills Summit - 2015
iHT2 Health IT Beverly Hills Summit - 2015iHT2 Health IT Beverly Hills Summit - 2015
iHT2 Health IT Beverly Hills Summit - 2015
Health IT Conference – iHT2
 

More from Health IT Conference – iHT2 (20)

2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit
 
2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit2016 iHT2 Miami Health IT Summit
2016 iHT2 Miami Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit2016 iHT2 San Diego Health IT Summit
2016 iHT2 San Diego Health IT Summit
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
 
2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum2015 Houston CHIME Lead Forum
2015 Houston CHIME Lead Forum
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
 
2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum2015 Atlanta CHIME Lead Forum
2015 Atlanta CHIME Lead Forum
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
 
2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit 2015 iHT2 Health IT Beverly Hills Summit
2015 iHT2 Health IT Beverly Hills Summit
 
iHT2 Health IT Beverly Hills Summit - 2015
iHT2 Health IT Beverly Hills Summit - 2015iHT2 Health IT Beverly Hills Summit - 2015
iHT2 Health IT Beverly Hills Summit - 2015
 

Recently uploaded

How To Update One2many Field From OnChange of Field in Odoo 17
How To Update One2many Field From OnChange of Field in Odoo 17How To Update One2many Field From OnChange of Field in Odoo 17
How To Update One2many Field From OnChange of Field in Odoo 17
Celine George
 
NAEYC Code of Ethical Conduct Resource Book
NAEYC Code of Ethical Conduct Resource BookNAEYC Code of Ethical Conduct Resource Book
NAEYC Code of Ethical Conduct Resource Book
lakitawilson
 
How to Empty a One2Many Field in Odoo 17
How to Empty a One2Many Field in Odoo 17How to Empty a One2Many Field in Odoo 17
How to Empty a One2Many Field in Odoo 17
Celine George
 
How To Create a Transient Model in Odoo 17
How To Create a Transient Model in Odoo 17How To Create a Transient Model in Odoo 17
How To Create a Transient Model in Odoo 17
Celine George
 
FINAL MATATAG Kindergarten CG 2023 pdf
FINAL MATATAG Kindergarten CG 2023   pdfFINAL MATATAG Kindergarten CG 2023   pdf
FINAL MATATAG Kindergarten CG 2023 pdf
maricelrudela
 
E-learning Odoo 17 New features - Odoo 17 Slides
E-learning Odoo 17  New features - Odoo 17 SlidesE-learning Odoo 17  New features - Odoo 17 Slides
E-learning Odoo 17 New features - Odoo 17 Slides
Celine George
 
Allopathic M1 Srudent Orientation Powerpoint
Allopathic M1 Srudent Orientation PowerpointAllopathic M1 Srudent Orientation Powerpoint
Allopathic M1 Srudent Orientation Powerpoint
Julie Sarpy
 
Mail Server Configuration Using App passwords in Odoo 17
Mail Server Configuration Using App passwords in Odoo 17Mail Server Configuration Using App passwords in Odoo 17
Mail Server Configuration Using App passwords in Odoo 17
Celine George
 
formative Evaluation By Dr.Kshirsagar R.V
formative Evaluation By Dr.Kshirsagar R.Vformative Evaluation By Dr.Kshirsagar R.V
formative Evaluation By Dr.Kshirsagar R.V
DrRavindrakshirsagar1
 
C# Interview Questions PDF By ScholarHat.pdf
C# Interview Questions PDF By ScholarHat.pdfC# Interview Questions PDF By ScholarHat.pdf
C# Interview Questions PDF By ScholarHat.pdf
Scholarhat
 
1. Importance_of_reducing_postharvest_loss.pptx
1. Importance_of_reducing_postharvest_loss.pptx1. Importance_of_reducing_postharvest_loss.pptx
1. Importance_of_reducing_postharvest_loss.pptx
UmeshTimilsina1
 
modul ajar kelas x bahasa inggris 24/254
modul ajar kelas x bahasa inggris 24/254modul ajar kelas x bahasa inggris 24/254
modul ajar kelas x bahasa inggris 24/254
NurFitriah45
 
How to Create a New Article in Knowledge App in Odoo 17
How to Create a New Article in Knowledge App in Odoo 17How to Create a New Article in Knowledge App in Odoo 17
How to Create a New Article in Knowledge App in Odoo 17
Celine George
 
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptxKesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
artenzmartenkai
 
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.pptFEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
JenezarieTarra1
 
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
Alvaro Barbosa
 
Odoo 17 Social Marketing - Lead Generation On Facebook
Odoo 17 Social Marketing - Lead Generation On FacebookOdoo 17 Social Marketing - Lead Generation On Facebook
Odoo 17 Social Marketing - Lead Generation On Facebook
Celine George
 
View Inheritance in Odoo 17 - Odoo 17 Slides
View Inheritance in Odoo 17 - Odoo 17  SlidesView Inheritance in Odoo 17 - Odoo 17  Slides
View Inheritance in Odoo 17 - Odoo 17 Slides
Celine George
 
SEQUNCES Lecture_Notes_Unit4_chapter11_sequence
SEQUNCES  Lecture_Notes_Unit4_chapter11_sequenceSEQUNCES  Lecture_Notes_Unit4_chapter11_sequence
SEQUNCES Lecture_Notes_Unit4_chapter11_sequence
Murugan Solaiyappan
 
Parent PD Design for Professional Development .docx
Parent PD Design for Professional Development .docxParent PD Design for Professional Development .docx
Parent PD Design for Professional Development .docx
AntonioJarligoCompra
 

Recently uploaded (20)

How To Update One2many Field From OnChange of Field in Odoo 17
How To Update One2many Field From OnChange of Field in Odoo 17How To Update One2many Field From OnChange of Field in Odoo 17
How To Update One2many Field From OnChange of Field in Odoo 17
 
NAEYC Code of Ethical Conduct Resource Book
NAEYC Code of Ethical Conduct Resource BookNAEYC Code of Ethical Conduct Resource Book
NAEYC Code of Ethical Conduct Resource Book
 
How to Empty a One2Many Field in Odoo 17
How to Empty a One2Many Field in Odoo 17How to Empty a One2Many Field in Odoo 17
How to Empty a One2Many Field in Odoo 17
 
How To Create a Transient Model in Odoo 17
How To Create a Transient Model in Odoo 17How To Create a Transient Model in Odoo 17
How To Create a Transient Model in Odoo 17
 
FINAL MATATAG Kindergarten CG 2023 pdf
FINAL MATATAG Kindergarten CG 2023   pdfFINAL MATATAG Kindergarten CG 2023   pdf
FINAL MATATAG Kindergarten CG 2023 pdf
 
E-learning Odoo 17 New features - Odoo 17 Slides
E-learning Odoo 17  New features - Odoo 17 SlidesE-learning Odoo 17  New features - Odoo 17 Slides
E-learning Odoo 17 New features - Odoo 17 Slides
 
Allopathic M1 Srudent Orientation Powerpoint
Allopathic M1 Srudent Orientation PowerpointAllopathic M1 Srudent Orientation Powerpoint
Allopathic M1 Srudent Orientation Powerpoint
 
Mail Server Configuration Using App passwords in Odoo 17
Mail Server Configuration Using App passwords in Odoo 17Mail Server Configuration Using App passwords in Odoo 17
Mail Server Configuration Using App passwords in Odoo 17
 
formative Evaluation By Dr.Kshirsagar R.V
formative Evaluation By Dr.Kshirsagar R.Vformative Evaluation By Dr.Kshirsagar R.V
formative Evaluation By Dr.Kshirsagar R.V
 
C# Interview Questions PDF By ScholarHat.pdf
C# Interview Questions PDF By ScholarHat.pdfC# Interview Questions PDF By ScholarHat.pdf
C# Interview Questions PDF By ScholarHat.pdf
 
1. Importance_of_reducing_postharvest_loss.pptx
1. Importance_of_reducing_postharvest_loss.pptx1. Importance_of_reducing_postharvest_loss.pptx
1. Importance_of_reducing_postharvest_loss.pptx
 
modul ajar kelas x bahasa inggris 24/254
modul ajar kelas x bahasa inggris 24/254modul ajar kelas x bahasa inggris 24/254
modul ajar kelas x bahasa inggris 24/254
 
How to Create a New Article in Knowledge App in Odoo 17
How to Create a New Article in Knowledge App in Odoo 17How to Create a New Article in Knowledge App in Odoo 17
How to Create a New Article in Knowledge App in Odoo 17
 
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptxKesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
Kesadaran_Berbangsa_dan_Bernegara_Nasion.pptx
 
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.pptFEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
FEELINGS AND EMOTIONS INSIDE OUT MOVIE.ppt
 
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
Benchmarking Sustainability: Neurosciences and AI Tech Research in Macau - Ke...
 
Odoo 17 Social Marketing - Lead Generation On Facebook
Odoo 17 Social Marketing - Lead Generation On FacebookOdoo 17 Social Marketing - Lead Generation On Facebook
Odoo 17 Social Marketing - Lead Generation On Facebook
 
View Inheritance in Odoo 17 - Odoo 17 Slides
View Inheritance in Odoo 17 - Odoo 17  SlidesView Inheritance in Odoo 17 - Odoo 17  Slides
View Inheritance in Odoo 17 - Odoo 17 Slides
 
SEQUNCES Lecture_Notes_Unit4_chapter11_sequence
SEQUNCES  Lecture_Notes_Unit4_chapter11_sequenceSEQUNCES  Lecture_Notes_Unit4_chapter11_sequence
SEQUNCES Lecture_Notes_Unit4_chapter11_sequence
 
Parent PD Design for Professional Development .docx
Parent PD Design for Professional Development .docxParent PD Design for Professional Development .docx
Parent PD Design for Professional Development .docx
 

2013 CPT Coding Update!

  • 1. 2013 CPT CODING UPDATE! CPT® is a registered trademark of the American Medical Association.
  • 2. CPT® 2013 code changes announced; new codes reflect care advancements  Allowphysicians to report advancements in healthcare services  Molecular Tests  Care Coordination  SINGLE LARGEST EXPANSION  186 New Codes Added  119 Outdated Codes Deleted  263 Another Revised Codes
  • 3. SINGLE LARGEST EXPANSION  Result of:  Significant advancements in medical understanding and testing for Molecular Disease  Including Human Genome Project  The 2013 codes include 116 for molecular pathology!
  • 4. New Codes Will Enhance..  Reporting of innovative diagnostic tools  Improve Health Outcomes  Reduce Long-Term Care Cost  Additional Updates  Reflect Practice Changes and Improvements in  Cardiology  Neurologic Testing  Psychiatry
  • 5. "Medical knowledge is constantly advancing, and as steward of CPT, the AMA invests extensive resources each year to keep the code set current with contemporary medical science and technology," AMA President Jeremy A. Lazarus, MD
  • 6. When is the code set updated?  The code set is updated annually with direct input from the health care community:  Practicing Physicians  Allied Health Professionals  Advisors from more than 100 medical specialty societies  Such input has allowed the code set to better support the reporting needs of physicians and other professionals in emerging models of care, including patient-centered medical homes and accountable care organizations.
  • 7. Click here for the 2013 CPT code changes  "Tapping into the clinical expertise of the health care community produces the practical enhancements that CPT needs to reflect the coding demands of the modern health care system," Dr. Lazarus said.
  • 8. A few CPT 2013 CPT codes.. Arthrodesis, pre-sacral interbody technique, including disc space preparation, discectomy,with posterior instrumentation, with image guidance, includes bone graft, when performed,lumbar, L4-L5 interspace (List separately in addition to code for primary 0309T procedure Motor function mapping using non-invasive navigated transcranial magnetic stimulation(nTMS) for therapeutic treatment planning, 0310T upper and lower extremity Non-invasive calculation and analysis of central arterial pressure 0311T waveforms withinterpretation and report Vagus nerve blocking therapy (morbid obesity); laparoscopic implantation of neurostimulator electrode array, anterior and posterior vagal trunks adjacent to esophagogastric junction(EGJ), 0312T with implantation of pulse generator, includes programming Vagus nerve blocking therapy (morbid obesity); laparoscopic revision or replacement of vagaltrunk neurostimulator electrode 0313T array, including connection to existing pulse generator
  • 9. Vagus nerve blocking therapy (morbid obesity); laparoscopic removal of vagal trunkneurostimulator electrode array and pulse 0314T generator Vagus nerve blocking therapy (morbid obesity); removal of pulse generator agus nerve blocking therapy (morbid obesity); removal of 0315T pulse generator Vagus nerve blocking therapy (morbid obesity); replacement of 0316T pulse generator Vagus nerve blocking therapy (morbid obesity); neurostimulator pulse generator electronicanalysis, includes reprogramming when performed 0317T Implantation of catheter-delivered prosthetic aortic heart valve, 0318T open thoracic approach, (eg,transapical, other than transaortic)
  • 10. Implantation of catheter-delivered prosthetic aortic heart valve, 0319T open thoracic approach, (eg,transapical, other than transaortic 0320T Insertion of subcutaneous defibrillator electrode Insertion of subcutaneous implantable defibrillator pulse generator 0321T only with existingsubcutaneous electrode Removal of subcutaneous implantable defibrillator pulse generator 0322T only Removal of subcutaneous implantable defibrillator pulse generator with replacement of subcutaneous implantable defibrillator pulse 0323T generator only
  • 11. 0324T Removal of subcutaneous defibrillator electrode Repositioning of subcutaneous implantable defibrillator electrode 0325T and/or pulse generator Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillationthreshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmiatermination, and programming or reprogramming of sensing or therapeutic 0326T parameters Interrogation device evaluation (in person) with analysis, review and report, includesconnection, recording and disconnection per patient encounter; implantable subcutaneouslead defibrillator 0327T system Programming device evaluation (in person) with iterative adjustment of the implantable deviceto test the function of the device and select optimal permanent programmed values 0328T withanalysis; implantable subcutaneous lead defibrillator system
  • 12. 0580F Multidisciplinary care plan developed or updated (DSP) Patient transferred directly from anesthetizing location to critical care 0581F unit (Peri2) Patient not transferred directly from anesthetizing location to critical 0582F care unit (Peri2) 0583F Transfer of care checklist used (Peri2) 0584F Transfer of care checklist not used (Peri2)
  • 13. Did we say a few? Symptoms and signs of distal symmetric polyneuropathy reviewed 1500F and documented (DSP) 1501F Not initial evaluation for condition (DSP Patient queried about pain and pain interference with function 1502F using a valid and reliableinstrument (DSP 1503F Patient queried about symptoms of respiratory insufficiency (DSP) 1504F Patient has respiratory insufficiency (DSP
  • 14. Arthrodesis, pre-sacral interbody technique, including disc space preparation, discectomy,with posterior instrumentation, with image 22586 guidance, includes bone graft when performed, L5-S1 interspace Revision of total shoulder arthroplasty, including allograft when 23473 performed; humeral or glenoidcomponent Revision of total shoulder arthroplasty, including allograft when 23474 performed; humeral andglenoid component Revision of total elbow arthroplasty, including allograft when 24370 performed; humeral or ulnar component Revision of total elbow arthroplasty, including allograft when 24371 performed; humeral and ulnar component
  • 15. Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloonocclusion, when performed, assessment of air leak, airway sizing, and 31647 insertion of bronchialvalve(s), initial lobe Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; withremoval of bronchial 31648 valve(s), initial lobe Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; withremoval of bronchial valve(s), each additional lobe (List separately in addition to 31649 code for primary procedure) Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with balloonocclusion, when performed, assessment of air leak, airway sizing, and insertion of bronchialvalve(s), each additional lobe (List 31651 separately in addition to code for primary procedure[s] Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; withbronchial thermoplasty, 1 31660 lobe
  • 16. Bronchoscopy, rigid or flexible, including fluoroscopic 31661 guidance, when performed; withbronchial thermoplasty, 2 or more lobes Thoracentesis, needle or catheter, aspiration of 32554 the pleural space; without imaging guidance Thoracentesis, needle or catheter, aspiration of 32555 the pleural space; with imaging guidance Pleural drainage, percutaneous, with insertion of 32556 indwelling catheter; without imagingguidance Pleural drainage, percutaneous, with insertion of 32557 indwelling catheter; with imaging guidance
  • 17. Thoracic target(s) delineation for stereotactic body 32701 radiation therapy (SRS/SBRT), (photon or particle beam), entire course of treatment Transcatheter aortic valve replacement (TAVR/TAVI) with 33361 prosthetic valve; percutaneousfemoral artery approach Transcatheter aortic valve replacement (TAVR/TAVI) with 33362 prosthetic valve; open femoralartery approach Transcatheter aortic valve replacement (TAVR/TAVI) with 33363 prosthetic valve; open axillaryartery approach Transcatheter aortic valve replacement (TAVR/TAVI) with 33364 prosthetic valve; open iliac arteryapproach
  • 18. Transcatheter aortic valve replacement (TAVR/TAVI) with 33365 prosthetic valve; transaorticapproach (eg, median sternotomy, mediastinotomy) Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonarybypass support with 33367 percutaneous peripheral arterial and venous cannulation (eg, femoralvessels) (List separately in addition to code for primary procedure) Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonarybypass support with 33368 open peripheral arterial and venous cannulation (eg, femoral, iliac,axillary vessels) (List separately in addition to code for primary procedure) Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonarybypass support with 33369 central arterial and venous cannulation (eg, aorta, right atrium,pulmonary artery) (List separately in addition to code for primary procedure) Insertion of ventricular assist device, percutaneous 33990 including radiological supervision andinterpretation; arterial access only Insertion of ventricular assist device, percutaneous 33991 including radiological supervision andinterpretation; both arterial and venous access, with transseptal puncture
  • 19. Removal of percutaneous ventricular assist device at 33992 separate and distinct session frominsertion Repositioning of percutaneous ventricular assist device 33993 with imaging guidance at separateand distinct session from insertion Non-selective catheter placement, thoracic aorta, with angiography of the extracranial carotid,vertebral, and/or intracranial vessels, unilateral or bilateral, and all 36221 associated radiologicalsupervision and interpretation, includes angiography of the cervicocerebral arch, whenperformed Selective catheter placement, common carotid or innominate artery, unilateral, any approach,with angiography of the ipsilateral extracranial carotid 36222 circulation and all associatedradiological supervision and interpretation, includes angiography of the cervicocerebral arch,when performed Selective catheter placement, common carotid or innominate artery, unilateral, any approach,with angiography of the ipsilateral intracranial carotid 36223 circulation and all associatedradiological supervision and interpretation, includes angiography of the extracranial carotidand cervicocerebral arch, when performed
  • 20. Selective catheter placement, internal carotid artery, unilateral, with angiography of theipsilateral intracranial carotid circulation and all associated radiological 36224 supervision andinterpretation, includes angiography of the extracranial carotid and cervicocerebral arch,when performed Selective catheter placement, subclavian or innominate artery, unilateral, with angiography of the ipsilateral 36225 vertebral circulation and all associated radiological supervision andinterpretation, includes angiography of the cervicocerebral arch, when performed Selective catheter placement, vertebral artery, unilateral, with angiography of the ipsilateralvertebral circulation and 36226 all associated radiological supervision and interpretation, includesangiography of the cervicocerebral arch, when performed Selective catheter placement, external carotid artery, unilateral, with angiography of theipsilateral external carotid 36227 circulation and all associated radiological supervision andinterpretation (List separately in addition to code for primary procedure) Selective catheter placement, each intracranial branch of the internal carotid or vertebralarteries, unilateral, with angiography of the selected vessel circulation and all 36228 associatedradiological supervision and interpretation (eg, middle cerebral artery, posterior inferior cerebellar artery) (List separately in addition to code for primary procedure)
  • 21. Transcatheter retrieval, percutaneous, of intravascular foreign body (eg, fractured venous or arterial catheter), 37197 includes radiological supervision and interpretation, and imaging guidance(ultrasound or fluoroscopy), when performed Transcatheter therapy, arterial infusion for thrombolysis 37211 other than coronary, any method,including radiological supervision and interpretation, initial treatment day Transcatheter therapy, venous infusion for thrombolysis, any 37212 method, including radiologicalsupervision and interpretation, initial treatment day Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, anymethod, including radiological supervision and interpretation, continued 37213 treatment onsubsequent day during course of thrombolytic therapy, including follow-up catheter contrastinjection, position change, or exchange, when performed; Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, anymethod, including radiological supervision and interpretation, continued treatment onsubsequent day during course of thrombolytic 37214 therapy, including follow-up catheter contrastinjection, position change, or exchange, when performed; cessation of thrombolysis includingremoval of catheter and vessel closure by any method
  • 22. Electrodiagnostic studies for distal symmetric polyneuropathy not conducted (or 3752F requested),documented, or reviewed within 6 months of initial evaluation for condition (DSP) Patient has clear clinical symptoms and signs that are highly suggestive of neuropathy ANDcannot be 3753F attributed to another condition, AND has an obvious cause for the neuropathy(DSP) Screening tests for diabetes mellitus reviewed, requested, 3754F or ordered (DSP) Cognitive and behavioral impairment screening 3755F performed (DSP) Patient has pseudobulbar affect, sialorrhea, or 3756F ALS related symptoms (DSP) Patient does not have pseudobulbar affect, sialorrhea, or 3757F ALS related symptoms (DSP) Patient referred for pulmonary function testing or peak 3758F cough expiratory flow (DSP)
  • 23. Take effect January 1, 2013.. Patient screened for dysphagia, weight loss, and 3759F impaired nutrition, and results documented(DSP) Patient exhibits dysphagia, weight loss, or impaired 3760F nutrition (DSP) Patient does not exhibit dysphagia, weight loss, or 3761F impaired nutrition (DSP) 3762F Patient is dysarthric (DSP) 3763F Patient is not dysarthric (DSP) 38243 Hematopoietic progenitor cell (HPC); HPC boost Esophagoscopy, rigid or flexible; with optical 43206 endomicroscopy
  • 24. Upper gastrointestinal endoscopy including esophagus, 43252 stomach, and either the duodenumand/or jejunum as appropriate; with optical endomicroscopy Preparation of fecal microbiota for instillation, 44705 including assessment of donor specimen 4540F Disease modifying pharmacotherapy discussed (DSP) Patient offered treatment for pseudobulbar affect, 4541F sialorrhea, or ALS related symptoms (DSP) Options for noninvasive respiratory support discussed with 4550F patient (DSP) 4551F Nutritional support offered (DSP) Patient offered referral to a speech language pathologist 4552F (DSP)
  • 25. Patient offered assistance in planning for end of life issues 4553F (DSP) 4554F Patient received inhalational anesthetic agent (Peri2) Patient did not receive inhalational anesthetic 4555F agent (Peri2) Patient exhibits 3 or more risk factors for post-operative 4556F nausea and vomiting (Peri2) Patient does not exhibit 3 or more risk factors for post- 4557F operative nausea and vomiting (Peri2) Patient received at least 2 prophylactic pharmacologic 4558F anti-emetic agents of different classespreoperatively and intraoperatively (Peri2) At least 1 body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees 4559F Fahrenheit) recorded within the 30 minutes immediately before or the 15minutes immediately after anesthesia end time (Peri2)
  • 26. Anesthesia technique did not involve general or neuraxial 4560F anesthesia (Peri2) 4561F Patient has a coronary artery stent (Peri2) 4562F Patient does not have a coronary artery stent (Peri2) Patient received aspirin within 24 hours prior to anesthesia 4563F start time (Peri2) Cystourethroscopy, with injection(s) for chemodenervation 52287 of the bladder Chemodenervation of muscle(s); muscle(s) innervated by 64615 facial, trigeminal, cervical spinaland accessory nerves, bilateral (eg, for chronic migraine) Thyroid uptake, single or multiple quantitative 78012 measurement(s) (including stimulation,suppression, or discharge, when performed)
  • 27. Thyroid imaging (including vascular flow, when 78013 performed); Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s)quantitative 78014 measurement(s) (including stimulation, suppression, or c discharge, whenperformed) Parathyroid planar imaging (including subtraction, when 78071 performed); with tomographic(SPECT) Parathyroid planar imaging (including subtraction, when performed); with tomographic(SPECT), and concurrently 78072 acquired computed tomography (CT) for anatomical localization DMD (dystrophin) (eg, Duchenne/Becker muscular 81161 dystrophy) deletion analysis, andduplication analysis, if performed APC (adenomatous polyposis coli) (eg, familial 81201 adenomatosis polyposis [FAP], attenuatedFAP) gene analysis; full gene sequence
  • 28. APC (adenomatous polyposis coli) (eg, familial 81202 adenomatosis polyposis [FAP], attenuatedFAP) gene analysis; known familial variants APC (adenomatous polyposis coli) (eg, familial 81203 adenomatosis polyposis [FAP], attenuatedFAP) gene analysis; duplication/deletion variants EGFR (epidermal growth factor receptor) (eg, non- small cell lung cancer) gene analysis,common variants 81235 (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q) GJB2 (gap junction protein, beta 2, 26kDa; connexin 26) 81252 (eg, nonsyndromic hearing loss)gene analysis; full gene sequence GJB2 (gap junction protein, beta 2, 26kDa; connexin 26) 81253 (eg, nonsyndromic hearing loss)gene analysis; known familial variants
  • 29. GJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (eg, nonsyndromic hearing loss)gene analysis, common 81254 variants (eg, 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)]) PTEN (phosphatase and tensin homolog) (eg, 81321 Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; full sequence analysis PTEN (phosphatase and tensin homolog) (eg, 81322 Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; known familial variant PTEN (phosphatase and tensin homolog) (eg, 81323 Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; duplication/deletion variant PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie- 81324 Tooth, hereditary neuropathy withliability to pressure palsies) gene analysis; duplication/deletion analysis
  • 30. PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie- 81325 Tooth, hereditary neuropathy withliability to pressure palsies) gene analysis; full sequence analysis PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie- 81326 Tooth, hereditary neuropathy withliability to pressure palsies) gene analysis; known familial variant 81479 Unlisted molecular pathology procedure Oncology (ovarian), biochemical assays of two proteins 81500 (CA-125 and HE4), utilizing serum,with menopausal status, algorithm reported as a risk score Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2microglobulin, 81503 transferrin and pre-albumin), utilizing serum, algorithm reported as a risk score Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, HbA1c,insulin, hs-CRP, 81506 adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma,algorithm reporting a risk score
  • 31. Fetal congenital abnormalities, biochemical assays of two 81508 proteins (PAPP-A, hCG [anyform]), utilizing maternal serum, algorithm reported as a risk score Fetal congenital abnormalities, biochemical assays of 81509 three proteins (PAPP-A, hCG [anyform], DIA), utilizing maternal serum, algorithm reported as a risk score Fetal congenital abnormalities, biochemical assays of 81510 three analytes (AFP, uE3, hCG [anyform]), utilizing maternal serum, algorithm reported as a risk score Fetal congenital abnormalities, biochemical assays of four analytes (AFP, uE3, hCG [anyform], DIA) utilizing maternal 81511 serum, algorithm reported as a risk score (may includeadditional results from previous biochemical testing) Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, total hCG,hyperglycosylated hCG, 81512 DIA) utilizing maternal serum, algorithm reported as a risk score 81599 Unlisted multianalyte assay with algorithmic analysis
  • 32. 82777 Galectin-3 Cell enumeration using immunologic selection and 86152 identification in fluid specimen (eg,circulating tumor cells in blood); Cell enumeration using immunologic selection and 86153 identification in fluid specimen (eg,circulating tumor cells in blood); physician interpretation and report, when required 86711 Antibody; JC (John Cunningham) virus Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, flow cytometry); 86828 qualitative assessment of the presence or absence of antibody(ies) to HLA Class I and Class II HLA antigens Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); 86829 qualitative assessment of the presence or absence of antibody(ies) to HLA Class I or Class II HLA antigens
  • 33. Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); 86830 antibody identification by qualitative panel using completeHLA phenotypes, HLA Class I Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); 86831 antibody identification by qualitative panel using completeHLA phenotypes, HLA Class II Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); 86832 high definition qualitative panel for identification of antibodyspecificities (eg, individual antigen per bead methodology), HLA Class I Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); 86833 high definition qualitative panel for identification of antibodyspecificities (eg, individual antigen per bead methodology), HLA Class II Antibody to human leukocyte antigens (HLA), solid phase 86834 assays (eg, microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class I
  • 34. Antibody to human leukocyte antigens (HLA), solid phase assays (eg, 86835 microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class II Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus, 87631 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reverse transcription and amplified probe technique, multipletypes or subtypes, 3-5 targets Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus, 87632 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reverse transcription and amplified probe technique, multipletypes or subtypes, 6-11 targets Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,influenza virus, coronavirus, metapneumovirus, 87633 parainfluenza virus, respiratory syncytialvirus, rhinovirus), multiplex reverse transcription and amplified probe technique, multipletypes or subtypes, 12-25 targets Infectious agent genotype analysis by nucleic acid (DNA or RNA); 87910 cytomegalovirus Infectious agent genotype analysis by nucleic acid (DNA or RNA); 87912 Hepatitis B virus
  • 35. Optical endomicroscopic image(s), interpretation and report, real- 88375 time or referred, eachendoscopic session Influenza vaccine, inactivated, subunit, adjuvanted, for 90653 intramuscular use 90672 Influenza virus vaccine, quadrivalent, live, for intranasal use Influenza virus vaccine, quadrivalent, split virus, preservative 90685 free, when administered tochildren 6-35 months of age, for intramuscular use Influenza virus vaccine, quadrivalent, split virus, preservative 90686 free, when administered toindividuals 3 years of age and older, for intramuscular use Influenza virus vaccine, quadrivalent, split virus, when administered to 90687 children 6-35 monthsof age, for intramuscular use Influenza virus vaccine, quadrivalent, split virus, when administered to 90688 individuals 3 years of age and older, for intramuscular use Hepatitis B vaccine, adult dosage (2 dose schedule), for 90739 intramuscular use
  • 36. Interactive complexity (List separately in addition to the 90785 code for primary procedure) 90791 Psychiatric diagnostic evaluation 90792 Psychiatric diagnostic evaluation with medical services Psychotherapy, 30 minutes with patient and/or family 90832 member Psychotherapy, 30 minutes with patient and/or family member when performed with anevaluation and 90833 management service (List separately in addition to the code for primaryprocedure) Psychotherapy, 45 minutes with patient and/or family 90834 member Psychotherapy, 45 minutes with patient and/or family member when performed with anevaluation and 90836 management service (List separately in addition to the code for primaryprocedure)
  • 37. Psychotherapy, 60 minutes with patient and/or family 90837 member Psychotherapy, 60 minutes with patient and/or family member when performed with anevaluation and 90838 management service (List separately in addition to the code for primaryprocedure) 90839 Psychotherapy for crisis; first 60 minutes Psychotherapy for crisis; each additional 30 minutes (List 90840 separately in addition to code for primary service) Pharmacologic management, including prescription and review of medication, whenperformed with psychotherapy 90863 services (List separately in addition to the code for primaryprocedure) Gastrointestinal transit and pressure measurement, stomach 91112 through colon, wireless capsule,with interpretation and report Percutaneous transluminal coronary angioplasty; single 92920 major coronary artery or branch
  • 38. Get more educational information on the next slide! Percutaneous transluminal coronary angioplasty; each 92921 additional branch of a major coronaryartery (List separately in addition to code for primary procedure) Percutaneous transluminal coronary atherectomy, with 92924 coronary angioplasty when performed;single major coronary artery or branch Percutaneous transluminal coronary atherectomy, with 92925 coronary angioplasty when performed;each additional branch of a major coronary artery (List separately in addition to code for primary procedure)
  • 39. Want to learn more?  Interested in getting more educational information? Click here for free white papers and research reports!  Reports & Data  Upcoming Webinars!  CPT Codes  The Institute for Health Technology Transformation is the leading organization committed to bringing together private and public sector leaders fostering the growth and effective use of technology across the healthcare industry.  PowerPoint brought to you by iHT2Blog.com